Ergoloid Mesylates: Clinical Trials

2 trials of Ergoloid Mesylates, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Ergoloid Mesylates: new trials by email Literature Review of Ergoloid Mesylates trials Research Report on Ergoloid Mesylates

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ERG/5-HTP in Fragile X Syndrome (FXS)
5-Hydroxytryptophan, Ergoloid Mesylates, Matching placebo for Ergoloid mesylates - Fragile X Syndrome
Phase 2CompletedElizabeth Berry-Kravis152021-10-072024-09-19
Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)
STA-1, Ergoloid Mesylates tablet - Vascular Dementia
Phase 2CompletedSinphar Pharmaceutical Co., Ltd2402002-03-012011-11-21

Conditions studied

Dementia, Vascular (1)  ·  Fragile X Syndrome (1)

Sponsors

Elizabeth Berry-Kravis (1)  ·  Sinphar Pharmaceutical Co., Ltd (1)

Countries

China (1)  ·  United States (1)

Top investigators

Elizabeth Berry-Kravis, MD, PhD (1)  ·  Mingjun Yang (1)